Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs YOURx Health

AM Rx
Graded #490

Lower grade

vs+20.1
YOURx Health
Graded #109

Higher grade

The verdict

YOURx Health takes it — 70/100 to 49.9/100.

YOURx Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. YOURx Health (yourxhealth.com) is a compounded GLP-1 telehealth platform powered by the MD Integrations provider network.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueYOURx Health +16
51
67
Dose & formulationYOURx Health +10
65
75
Clinical oversightYOURx Health +39
41
80
Labs & monitoringYOURx Health +26
49
75
FulfillmentAM Rx +3
58
55
Contract termsYOURx Health +35
20
55
AM Rx · left barYOURx Health · right bar

The numbers

MetricAM RxYOURx Health
WeighScore49.9/10070/100
GradeCC
Scorecard rank#490#109
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)$179/mo (compounded)
TirzepatideNot disclosed$199/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
AM Rx

Graded #490 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
YOURx Health

Graded #109 · C

Strengths

  • Lab monitoring included (per the home page) — most peer platforms gate labs as add-ons or skip them entirely
  • Physician video consultation with 'board-certified provider' disclosed
  • MD Integrations network is a recognized white-label clinical platform
  • Transparent published pricing: semaglutide injection $179/mo, tirzepatide injection $199/mo, oral RDT tablets $159-$179/mo

Where it loses points

  • Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
  • NO LegitScript / NABP / PCAB / BBB seal displayed — material trust-signal gap vs peer platforms
  • Per-state availability shown as 'Coverage 0 States' (placeholder metric) — appears the home page is incomplete or the platform is pre-launch
  • Pharmacy partners NOT publicly named
  • Confidence LOW until the platform exposes more public information

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard